SSAT - Surgery for Early Esophageal Cancer: Operative Outcome and Long-Term Survival

Back to 2014 Annual Meeting Posters

Surgery for Early Esophageal Cancer: Operative Outcome and Long-Term Survival
Vyacheslav Bard^*, Michael Stein, Nikolai Menasherov, Hanoch Kashtan
surgery, Beilinson Hospital, Petach-Tiqva, Israel

BACKGROUND: Early esophageal cancer is a curable disease with a favorable five-year survival. Surgery alone is considered to be the treatment of choice in such cases. Here we present our experience with early esophageal cancer.
PATIENTS AND METHODS: All patients with a diagnosis early esophageal cancer (T0-2N0) were operated with a curative intent between 2000 and 2012. A retrospective analysis of post operative outcomes as well as long term survival was performed.
RESULTS: There were 64 (46 males and 18 females, average age - 66) patients who were surgically treated for early esophageal cancer. There were 52 (81%) cases of adenocarcinoma and 12 cases of squamous carcinoma. High grade dysplasia (T0) was diagnosed in 8 (14.3% patients), T1 in 41 (65.1%) patients and T2 13(20.6%). There was no perioperative mortality. Overall morbidity rate was 33.9%. Crude 5-year survival rate was noted in 51 patients (79.6%). Of the 13 patients who died during the follow up period, 4 died of recurrent or metastatic disease (24-47 months after surgery) and 9 died of other causes.
CONCLUSION: Surgical resection remains the treatment approach for early esophageal cancer. It can be safely performed with a relative low incidence of morbidity and mortality. It provides a 5-year median survival rate of 80%.

Back to 2014 Annual Meeting Posters